Acta Chir Orthop Traumatol Cech. 2020; 87(5):363-366 | DOI: 10.55095/achot2020/056

Acute Limb Ischemia after Total Hip Arthroplasty in a High-Risk Patient - Is Tranexamic Acid to Blame?Case report

J. MASARYK1,*, J. VIDAN1, B. ŠTEŇO2
1 Ortopedické oddelenie Fakultnej nemocnice Trenčín
2 II. ortopedicko-traumatologická klinika Lekárskej fakulty Univerzity Komenského a Univerzitnej nemocnice Bratislava, Nemocnica sv. Cyrila a Metoda, Bratislava

Tranexamic acid (TXA) is widely used to limit the blood loss during total joint arthroplasty without an increased risk of thromboembolic events. We present a case of acute limb ischaemia due to thrombotic occlusion of the superficial femoral artery on the non-operated limb following a total hip arthroplasty in a 64-year-old male patient. Untreated peripheral artery disease, intravenous TXA administration, surgery, obesity and hypertension were identified as predisposing factors of the occlusion. Good reperfusion of the limb was obtained after mechanical thrombectomy. Other cases report that antifibrinolytic agents such as TXA could be associated with arterial thrombosis. The necessity to detect the risk factors of thrombotic events in each patient scheduled for total joint arthroplasty is emphasized. Therefore, topical TXA administration could be a reasonable alternative in a high-risk patient.

Keywords: tranexamic acid complications, total hip arthroplasty, arterial thrombosis

Published: October 1, 2020  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
MASARYK J, VIDAN J, ŠTEŇO B. Acute Limb Ischemia after Total Hip Arthroplasty in a High-Risk Patient - Is Tranexamic Acid to Blame? Acta Chir Orthop Traumatol Cech. 2020;87(5):363-366. doi: 10.55095/achot2020/056. PubMed PMID: 33146607.
Download citation

References

  1. Ausen K, Pleym H, Liu J, Hegstad S, Nordgård HB, Pavlovic I, Spigset O. Serum concentrations and pharmacokinetics of tranexamic acid after two means of topical administration in massive weight loss skin-reducing surgery. Plast Reconstr Surg. 2019;143:1169e-1178e. Go to original source... Go to PubMed...
  2. Bridges KH, Wilson SH. Acute coronary artery thrombus after tranexamic acid during total shoulder arthroplasty in a patient with coronary stents: a case report. A A Pract. 2018;10:212-214. Go to original source... Go to PubMed...
  3. Calapai G, Gangemi S, Mannucci C, Minciullo PL, Casciaro M, Calapai F, Righi M, Navarra M. Systematic review of tranexamic acid adverse reactions. J Pharmacovigilance. 2015;3:4. Go to original source...
  4. Čertík B, Třeška V. Akutní končetinová ischemie. 1. vyd., Grada Publishing, Praha, 2003.
  5. Fillingham YA, Ramkumar DB, Jevsevar DS, Yates AJ, Bini SA, Clarke HD, Della Valle CJ. Tranexamic acid use in total joint arthroplasty: the clinical practice guidelines endorsed by the American Association of Hip and Knee Surgeons, American Society of Regional Anesthesia and Pain Medicine, American Academy of Orthopaedic Surgeons, Hip Society, and Knee Society. J Arthroplasty. 2018;33:3065-3069. Go to original source... Go to PubMed...
  6. Gupta PN, Mullamalla UR, Sabin P, Vellappan P. Acute MI in a young hypertensive woman: could it be due to tranexamic acid? BMJ Case Rep. 2013. Go to original source...
  7. Hajmurad OS, Choxi AA, Zahid Z, Dudaryk R. Aortoiliac thrombosis following tranexamic acid administration during urgent cesarean hysterectomy: a case report. A A Case Rep. 2017;9:90-93. Go to original source... Go to PubMed...
  8. Chung E, Karlberg HI. Ulnar artery thrombosis following tranexamic acid administration for craniosynostosis repair. J Craniofac Surg. 2019;30:186-187. Go to original source... Go to PubMed...
  9. Juhan-Vague I, Pyke SD, Alessi MC, Jespersen J, Haverkate F, Thompson SG. Fibrinolytic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. ECAT Study Group. European Concerted Action on Thrombosis and Disabilities. Circulation. 1996;94:2057-2063. Go to original source... Go to PubMed...
  10. Lostak J, Gallo J, Slavik L, Zapletalova J, Balaz L. Monitoring of fibrinolytic system activity with plasminogen, D-dimers and FDP in primary total knee arthroplasty (TKA) after topical, intravenous or combined administration of tranexamic acid. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. [epub 2019], 2020;164:168-176.
  11. Lošťák J, Gallo J, Večeřa M, Špička J, Langová K. [Local application of tranexamic acid in total hip arthroplasty decreases blood loss and consumption of blood transfusion]. Acta Chir Orthop Traumatol Cech. 2017;84:254-262. Go to original source... Go to PubMed...
  12. Mannová J, Kubát P, Pospíchal M, Longin P. [Evaluation of efficacy of systemic administration of tranexamic acid (Exacyl) in total hip and knee arthroplasty - prospective cohort study]. Acta Chir Orthop Traumatol Cech. 2019;86:118-123. Go to original source... Go to PubMed...
  13. Salam A, King C, Orhan O, Mak V. The great deception: tranexamic acid and extensive pulmonary emboli. BMJ Case Rep. 2013. Go to original source...
  14. Upadhyay SP, Mallick PN, Jagia M, Singh RK. A acute arterial thrombosis associated with inadvertent high dose of tranexamic acid. Indian J Crit Care Med. 2013;17:237-239. Go to original source... Go to PubMed...
  15. Zhou Z-F, Zhang F-J, Huo Y-F, Yu Y-X, Yu L-N, Sun K, Sun L-H, Xing X-F, Yan M. Intraoperative tranexamic acid is associated with postoperative stroke in patients undergoing cardiac surgery. PLoS One. 2017;12:e0177011. Go to original source... Go to PubMed...